TScan Therapeutics VP Finance Resigns, 8-K Filed Apr 2 TScan filed an 8-K on Apr 2, 2026 reporting its vice president of finance resignation (published 11:43:16 GMT). Expect follow-up filings to clarify succession and cash-runway implications.

TScan Therapeutics VP Finance Resigns, 8-K Filed Apr 2: TScan filed an 8-K on Apr 2, 2026 reporting its vice president of finance resignation (published 11:43:16 GMT). Expect follow-up filings to clarify succession… 👈 Read full analysis #TScan #FinanceNews #ExecutiveResignation #8KFilings #Investing